Xebra Brands has announced the development of the Strategic 2025 Roadmap, a comprehensive commercial growth plan designated to expand its footprint in the North American CBD market. Developed in collaboration with a consulting firm specializing in Cannabis and CBD, the Strategic 2025 Roadmap outlines a clear roadmap to drive accelerated growth and market penetration.
The North American cannabidiol (CBD) market has experienced significant growth over the past five years. According to Grand View Research, the market was valued at approximately USD 6.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2030.
"As the first and only Mexican company ever to hold an authorization from the COFEPRIS (Mexican FDA) mandated by the Supreme Court, Xebra' is uniquely positioned to capitalize on the international growth trends in CBD. 'Xebra's strategic growth pillars will be centered on Domestic CBD Cultivation, CBD Manufacturing and Rapid Retail Distribution," said Rodrigo Gallardo Interim CEO.
For more information:
Xebra Brands
www.xebrabrands.com